DLL4 and pancreatic neoplasm: Adam et al. [109] proposed a new concept in the nanoparticle targeting of sdAds, i.e., anti-DLL4 VNARs were specifically conjugated with a target in DLL4 and used as a new treatment for pancreatic cancer.